Clinical Trial

Intelligent Approach to Traditional Chinese Medicine for Insomnia

Study acronym: TCM
Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated May 30, 2025 (before its estimated December 19, 2025 completion). Its status may not reflect the trial's current state.
Summary
Insomnia is a very common health issue, affecting over 40% of the population in Chinese-speaking regions. The impact of insomnia on society, economy, mental health, and physical health is significant, with previous research indicating that insomnia is associated with an increased risk of high blood pressure, heart disease, anxiety, and depression, which can ultimately lead to a decline in quality of life. Treatment for insomnia includes non-pharmacological and pharmacological interventions, with clinical practice often utilizing sedative medications for sleep, but with side effects such as dependency, tolerance, daytime drowsiness, and withdrawal symptoms, which make it challenging for patients to find suitable medical treatment. Traditional Chinese Medicine (TCM) approaches insomnia by first conducting a thorough assessment based on individualized patterns (differentiation of body constitution) and evaluating insomnia-related symptoms, followed by an examination of tongue and pulse to determine the correct treatment plan, which may involve acupuncture, herbal medicine or a combination of both (integrative treatment). Due to the complex nature of insomnia, a definitive diagnosis requires neuroimaging and other measures during sleep studies to assess brain wave activity, if possible, to understand the cognitive impact.
Trial Details
NCT Number NCT06997289
Lead Sponsor Taipei Veterans General Hospital, Taiwan
Conditions Insomnia
Enrollment 120 participants
Start Date 2025-05-28
Primary Completion 2025-12-19 (estimated)
Study Completion 2025-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-05-30